Publications

For the past two decades the Survey on Health and Use on National Defence and Citizenship Day (ESCAPAD) conducted by the OFDT has made it possible to quantify the use of psychoactive substance by 17-year-olds at a regional level.

Behavioural addictions still make up a scientific and clinical field under construction, characterised by a low consensus level which results in large numbers of concepts, terms, definitions and measuring tools.

The study on the use of analgesic opioid medicines (EMOA) by the French Monitoring Centre for Drugs and Drug Addiction (OFDT) examines their prescription in general practice and the experiences of who consider themselves to be having difficulty with them in the treatment of chronic pain unrelated to cancer in France.

This review of the social science publications on trajectories to quit smoking begins with an account of surveys looking at methods used to help smokers quit and professionals involved in helping them. The second part of the report deals with studies analysing the impact of socioeconomic variables on smoking behaviour and/or cessation.

Quebec was one of the most reluctant provinces when the federal government announced its decision to legalise cannabis for non-medical use.

Among the range of cannabis regulatory systems introduced in North America, the example of British Columbia demonstrates a cautious regulatory approach, centred on the gradual introduction of cannabis on the market, which is designed to be reasonable and guided by a step-by-step evaluation of the reform.

Canada legalised cannabis for non-medical use in October 2018. While the federal government organises the production of cannabis, it has left it up to its 13 provinces and territories to define a distribution and retail model. Ontario, the most populous province and largest cannabis market in Canada, is at the forefront of this process.

In the general context of a background of booming global cocaine production, this Théma report provides an assessment of the situation in France.

A review of the international literature on online sports betting demonstrates that current knowledge about so-called “problem” sports betting remains largely unknown. Although the data is incomplete among the general population, “excessive” practices have nevertheless been noted, in particular through surveys of Internet users.

The aim of this Théma is to provide an overview of the situations and problems currently observed in the French overseas territories with regard to drugs and addictions, based on the most recent statistical data and the main studies carried out in these territories.

This is a review and synthesis of the scientific literature on public health effects of liberalization of marijuana prohibition in the United States. 

This report summarizes eight years of policy and public health knowledge since Colorado and Washington became the first states in the U.S. – and the first jurisdictions in the world – to begin to develop and implement policies around a commercial marketplace for marijuana.

This report analyzes the regulation of cannabis in Canada, as well as the political, economic and social impact of the policies adopted.

On the 20th anniversary of the Emerging Trends and New Drugs (TREND) scheme and the National Detection System of Drugs and Toxic Substances (SINTES), the French Monitoring Centre for Drugs and Drug Addiction (OFDT) looks back on two decades of drug monitoring. 

What is the extent and nature of illicit drug use in prisons in France? What are the consequences and what responses are being provided?

This Théma report is devoted to the changes in the cannabis market in France, particularly in relation to the increase in the use of herbal cannabis.

This summary covers the main contributions from a collective OFDT publication entitled "Drogues et addictions, données essentielles" issued in April 2019.

Within the vast category of new psychoactive substances, 25x-NBOMe or NBOMe represents a group of compounds in the phenethylamine family, which mainly has a hallucinogenic and psychedelic effect in particular.

Until now, most of our available knowledge on the NPS (new/novel psychoactive substance) phenomenon originated from traditional information systems on drugs and drug addiction (data on seizures and treatment demands, monitoring in a recreational setting, etc.).